{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:29:19Z","timestamp":1786580959842,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["20H03619"],"award-info":[{"award-number":["20H03619"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-026-00460-0","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:44:10Z","timestamp":1780919050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of NOTA-based antibody-fragment labeling agent that reduces early renal radioactivity levels"],"prefix":"10.1186","volume":"11","author":[{"given":"Shunsuke","family":"Katamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-4274","authenticated-orcid":false,"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Kannaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuki","family":"Kazuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-9800","authenticated-orcid":false,"given":"Tomoya","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"4","key":"460_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0969-8051(01)00207-4","volume":"28","author":"H Akizawa","year":"2001","unstructured":"Akizawa H, Arano Y, Mifune M, Iwado A, Saito Y, Uehara T, et al. Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides. Nucl Med Biol. 2001;28(4):459\u201368.","journal-title":"Nucl Med Biol"},{"key":"460_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.nucmedbio.2020.03.001","volume":"92","author":"Y Arano","year":"2021","unstructured":"Arano Y. Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides. Nucl Med Biol. 2021;92:149\u201355.","journal-title":"Nucl Med Biol"},{"issue":"5","key":"460_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/ph16050696","volume":"16","author":"P Barta","year":"2023","unstructured":"Barta P, Nachtigal P, Maixnerova J, Zemankova L, Trejtnar F. Validation of freshly isolated rat renal cells as a tool for preclinical assessment of radiolabeled receptor-specific peptide uptake in the kidney. Pharmaceuticals (Basel). 2023;16(5):696.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"17","key":"460_CR25","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/molecules25173854","volume":"25","author":"S Bendre","year":"2020","unstructured":"Bendre S, Zhang Z, Kuo HT, Rousseau J, Zhang C, Merkens H, et al. Evaluation of Met-Val-Lys as a renal brush border enzyme-cleavable linker to reduce kidney uptake of 68Ga-Labeled DOTA-conjugated peptides and peptidomimetics. Molecules. 2020;25(17):3854.","journal-title":"Molecules"},{"issue":"8","key":"460_CR6","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/bc3002437","volume":"23","author":"P Fournier","year":"2012","unstructured":"Fournier P, Dumulon-Perreault V, Ait-Mohand S, Tremblay S, Benard F, Lecomte R, et al. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu\/and (68)Ga\/NOTA-PEG-[D-Tyr(6),betaAla(11),Thi(13),Nle(14)]BBN(6\u201314). Bioconjug Chem. 2012;23(8):1687\u201393.","journal-title":"Bioconjug Chem"},{"issue":"6","key":"460_CR27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1021\/bc050211z","volume":"16","author":"Y Fujioka","year":"2005","unstructured":"Fujioka Y, Satake S, Uehara T, Mukai T, Akizawa H, Ogawa K, et al. In vitro system to estimate renal brush border enzyme-mediated cleavage of peptide linkages for designing radiolabeled antibody fragments of low renal radioactivity levels. Bioconjug Chem. 2005;16(6):1610\u20136.","journal-title":"Bioconjug Chem"},{"key":"460_CR5","unstructured":"IAEA. Copper-64 Radiopharmaceuticals: Production, quality control and clinical applications. PO Box 100, 1400 Vienna, Austria: IAEA; 2022."},{"issue":"5","key":"460_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1021\/acs.molpharmaceut.1c00946","volume":"19","author":"K Jendryczko","year":"2022","unstructured":"Jendryczko K, Rzeszotko J, Krzyscik MA, Kocyla A, Szymczyk J, Otlewski J, et al. Drug conjugation via maleimide-thiol chemistry does not affect targeting properties of cysteine-containing anti-FGFR1 peptibodies. Mol Pharm. 2022;19(5):1422\u201333.","journal-title":"Mol Pharm"},{"issue":"3","key":"460_CR3","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/acs.jmedchem.4c02885","volume":"68","author":"P Krecisz","year":"2025","unstructured":"Krecisz P, Stefanska K, Studzinski J, Pitucha M, Czylkowska A, Szymanski P. Radiocopper in radiopharmacy and medical use: current status and perspective. J Med Chem. 2025;68(3):2356\u201376.","journal-title":"J Med Chem"},{"issue":"2","key":"460_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/mmr.2023.13155","volume":"29","author":"F Lundmark","year":"2024","unstructured":"Lundmark F, Vorobyeva A, Liu Y, Lindbo S, Xu T, Oroujeni M, et al. Reduction of renal activity retention of radiolabeled albumin binding domain\u2013derived affinity proteins using a non\u2013residualizing label strategy compared with a cleavable glycine\u2013leucine\u2013glycine\u2013lysine\u2013linker. Mol Med Rep. 2024;29(2):1\u20138.","journal-title":"Mol Med Rep"},{"key":"460_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.mie.2020.02.023","volume":"638","author":"R Maloney","year":"2020","unstructured":"Maloney R, Buuh ZY, Zhao Y, Wang RE. Site-specific antibody fragment conjugates for targeted imaging. Methods Enzymol. 2020;638:295\u2013320.","journal-title":"Methods Enzymol"},{"issue":"5","key":"460_CR20","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1021\/acs.molpharmaceut.5c00041","volume":"22","author":"T Peng","year":"2025","unstructured":"Peng T, Wang C, Wen J, Zhang Q, Wang C, Lv C, et al. 68Ga-NOTA-m-SNA006: a next-generation CD8-targeting nanobody probe to enhance renal and hepatic clearance in noninvasive immunoPET imaging. Mol Pharm. 2025;22(5):2639\u201349.","journal-title":"Mol Pharm"},{"issue":"2","key":"460_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2967\/jnumed.115.161703","volume":"57","author":"M Persson","year":"2016","unstructured":"Persson M, Nedergaard MK, Brandt-Larsen M, Skovgaard D, Jorgensen JT, Michaelsen SR, et al. Urokinase-type plasminogen activator receptor as a potential PET biomarker in glioblastoma. J Nucl Med. 2016;57(2):272\u20138.","journal-title":"J Nucl Med"},{"issue":"13","key":"460_CR16","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1021\/acs.jmedchem.3c00258","volume":"66","author":"H Suzuki","year":"2023","unstructured":"Suzuki H, Araki M, Tatsugi K, Ichinohe K, Uehara T, Arano Y. Reduction of the renal radioactivity of 111In-DOTA-labeled antibody fragments with a linkage cleaved by the renal brush border membrane enzymes. J Med Chem. 2023;66(13):8600\u201313.","journal-title":"J Med Chem"},{"issue":"4","key":"460_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/ph17040508","volume":"17","author":"H Suzuki","year":"2024","unstructured":"Suzuki H, Kannaka K, Uehara T. Approaches to reducing normal tissue radiation from radiolabeled antibodies. Pharmaceuticals (Basel). 2024;17(4):508.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"33","key":"460_CR10","doi-asserted-by":"publisher","first-page":"21556","DOI":"10.1021\/acsomega.1c02516","volume":"6","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kise S, Kaizuka Y, Watanabe R, Sugawa T, Furukawa T, et al. Copper-64-labeled antibody fragments for immuno-PET\/radioimmunotherapy with low renal radioactivity levels and amplified tumor-kidney ratios. ACS Omega. 2021;6(33):21556\u201362.","journal-title":"ACS Omega"},{"issue":"16","key":"460_CR2","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1039\/D5CS00392J","volume":"54","author":"KS Tanwar","year":"2025","unstructured":"Tanwar KS, Pandey MK. Gallium-68-labeled radiopharmaceuticals: a review. Chem Soc Rev. 2025;54(16):7421\u201383.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"460_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41181-023-00206-2","volume":"8","author":"B Trachsel","year":"2023","unstructured":"Trachsel B, Valpreda G, Lutz A, Schibli R, Mu L, Behe M. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK. EJNMMI Radiopharm Chem. 2023;8(1):21.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"460_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/bc0602329","volume":"18","author":"T Uehara","year":"2007","unstructured":"Uehara T, Koike M, Nakata H, Hanaoka H, Iida Y, Hashimoto K, et al. Design, synthesis, and evaluation of [188Re]organorhenium- labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels. Bioconjug Chem. 2007;18(1):190\u20138.","journal-title":"Bioconjug Chem"},{"issue":"11","key":"460_CR11","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1021\/bc5004058","volume":"25","author":"T Uehara","year":"2014","unstructured":"Uehara T, Rokugawa T, Kinoshita M, Nemoto S, Fransisco Lazaro GG, Hanaoka H, et al. 67\/68Ga-labeling agent that liberates 67\/68Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels. Bioconjug Chem. 2014;25(11):2038\u201345.","journal-title":"Bioconjug Chem"},{"issue":"14","key":"460_CR12","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1158\/1078-0432.CCR-18-0123","volume":"24","author":"T Uehara","year":"2018","unstructured":"Uehara T, Yokoyama M, Suzuki H, Hanaoka H, Arano Y. A Gallium-67\/68-labeled antibody fragment for immuno-SPECT\/PET shows low renal radioactivity without loss of tumor uptake. Clin Cancer Res. 2018;24(14):3309\u201316.","journal-title":"Clin Cancer Res"},{"key":"460_CR19","doi-asserted-by":"publisher","first-page":"117040","DOI":"10.1016\/j.bmc.2022.117040","volume":"73","author":"G Valpreda","year":"2022","unstructured":"Valpreda G, Trachsel B, Vogel V, Schibli R, Mu L, Behe M. Dual MVK cleavable linkers effectively reduce renal retention of 111In-fibronectin-binding peptides. Bioorg Med Chem. 2022;73:117040.","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"460_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","volume":"51","author":"E Vegt","year":"2010","unstructured":"Vegt E, de Jong M, Wetzels JF, Masereeuw R, Melis M, Oyen WJ, et al. Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. J Nucl Med. 2010;51(7):1049\u201358.","journal-title":"J Nucl Med"},{"issue":"30","key":"460_CR9","doi-asserted-by":"publisher","first-page":"e2402361","DOI":"10.1002\/advs.202402361","volume":"11","author":"Z Wei","year":"2024","unstructured":"Wei Z, Li B, Wen X, Jakobsson V, Liu P, Chen X, et al. Engineered antibodies as cancer radiotheranostics. Adv Sci (Weinh). 2024;11(30):e2402361.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"460_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00775-015-1318-7","volume":"21","author":"N Wu","year":"2016","unstructured":"Wu N, Kang CS, Sin I, Ren S, Liu D, Ruthengael VC, et al. Promising bifunctional chelators for copper 64-PET imaging: practical 64Cu radiolabeling and high in vitro and in vivo complex stability. J Biol Inorg Chem. 2016;21(2):177\u201384.","journal-title":"J Biol Inorg Chem"},{"issue":"6","key":"460_CR21","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00259-023-06584-8","volume":"51","author":"M Zhang","year":"2024","unstructured":"Zhang M, Kang F, Xing T, Wang J, Ma T, Li G, et al. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [(68)Ga]Ga-HER2 Affibody. Eur J Nucl Med Mol Imaging. 2024;51(6):1713\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"460_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","volume":"10","author":"S Zhang","year":"2025","unstructured":"Zhang S, Wang X, Gao X, Chen X, Li L, Li G, et al. Radiopharmaceuticals and their applications in medicine. Signal Transduct Target Ther. 2025;10(1):1.","journal-title":"Signal Transduct Target Ther"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-026-00460-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:03:09Z","timestamp":1786579389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-026-00460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s41181-026-00460-0","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal studies were conducted in accordance with the institutional guidelines approved by the Chiba University Animal Care Committee. Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}